GL1X · GenesisL1 explorer

UniProt P08179

Glycinamide ribonucleotide transformylase (P08179)

Glycinamide ribonucleotide transformylase (UniProt P08179), EC 2.1.2.2: 18 experimental structures and 1 predicted model on GenesisL1, 7 ligands bound, 59 pockets. Binding sites, druggability and experiment against prediction…

UniProt
P08179
Protein
Glycinamide ribonucleotide transformylase
EC
2.1.2.2
Experimental structures
18
Predicted models
1
Ligands
7
Pockets
59 · 13 records with a druggable one

Structures

19 records of P08179 in the MolNFT archive: 18 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1C2TNew insights into inhibitor design from the crystal structure and NMR studies of E. COLI gar…x-ray diffractionA, BNHS, GAR4 (best 0.68)
1C2TNew insights into inhibitor design from the crystal structure and NMR studies of E. COLI gar…x-ray diffractionA, BNHS, GAR4 (best 0.68)
1C3ENew insights into inhibitor design from the crystal structure and NMR studies of E. COLI gar…x-ray diffractionANHR, GAR3 (best 0.65)
1C3ENew insights into inhibitor design from the crystal structure and NMR studies of E. COLI gar…x-ray diffractionANHR, GAR3 (best 0.65)
1CDDStructures of apo and complexed escherichia COLI glycinamide ribonucleotide transformylasex-ray diffractionA, BPO43 (best 0.42)
1CDDStructures of apo and complexed escherichia COLI glycinamide ribonucleotide transformylasex-ray diffractionA, BPO43 (best 0.42)
1CDEStructures of apo and complexed escherichia COLI glycinamide ribonucleotide transformylasex-ray diffractionA, B, C, DGAR, DZF4 (best 0.65)
1CDEStructures of apo and complexed escherichia COLI glycinamide ribonucleotide transformylasex-ray diffractionA, B, C, DGAR, DZF4 (best 0.65)
1GARTowards structure-based drug design: crystal structure of a multisubstrate adduct complex of…x-ray diffractionA, BU893 (best 0.60)
1GARTowards structure-based drug design: crystal structure of a multisubstrate adduct complex of…x-ray diffractionA, BU893 (best 0.60)
1GRCCrystal structure of glycinamide ribonucleotide transformylase from escherichia COLI at 3.0…x-ray diffractionA, BPO43 (best 0.38)
1GRCCrystal structure of glycinamide ribonucleotide transformylase from escherichia COLI at 3.0…x-ray diffractionA, BPO43 (best 0.38)
1JKXUnexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of…x-ray diffractionA, B, C, D1387 (best 0.63)
1JKXUnexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of…x-ray diffractionA, B, C, D1387 (best 0.63)
2GARA pH-dependent stablization of an active site loop observed from low and high pH crystal structures…x-ray diffractionAPO41 (best 0.35)
2GARA pH-dependent stablization of an active site loop observed from low and high pH crystal structures…x-ray diffractionAPO41 (best 0.35)
3GARA pH-dependent stablization of an active site loop observed from low and high pH crystal structures…x-ray diffractionAPO41 (best 0.59)
3GARA pH-dependent stablization of an active site loop observed from low and high pH crystal structures…x-ray diffractionAPO41 (best 0.59)
P08179AlphaFold monomer V2.0 prediction for phosphoribosylglycinamide formyltransferase (P08179)predictedA—1 (best 0.63)

Ligands

  • PO4 · Phosphate ion · in 8 records
  • GAR · Glycinamide ribonucleotide · in 6 records
  • 138 · N-[5'-O-phosphono-ribofuranosyl]-2-[2-hydroxy-2-[4-[glutamic acid]-N-carbonylphenyl]-3-[2-amino-4-hydroxy-quinazolin-6-yl]-propanylamino]-acetamide · in 2 records
  • DZF · 5-deazafolic acid · in 2 records
  • NHR · 2-{4-[2-(2-amino-4-hydroxy-quinazolin-6-yl)-1-carboxy-ethyl]-benzoylamino}-pentanedioic acid · in 2 records
  • NHS · 10-formyl-5,8,10-trideazafolic acid · in 2 records
  • U89 · N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-4-pyrimidinyl)-propyl]-[2-((2-oxo-2-((4-phosphoriboxy)-butyl)-amino)-ethyl)-thio-acetyl]-amino]benzoyl]-1-glutamic acid · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.